Senhwa Biosciences Statistics

Total Valuation

TPEX:6492 has a market cap or net worth of TWD 2.89 billion. The enterprise value is 1.94 billion.

Market Cap	2.89B
Enterprise Value	1.94B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6492 has 89.19 million shares outstanding.

Current Share Class	89.19M
Shares Outstanding	89.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.04%
Owned by Institutions (%)	0.17%
Float	68.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,889.61
PB Ratio	2.99
P/TBV Ratio	2.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.65
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 43.57, with a Debt / Equity ratio of 0.01.

Current Ratio	43.57
Quick Ratio	43.22
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-487.03

Financial Efficiency

Return on equity (ROE) is -26.27% and return on invested capital (ROIC) is -16.87%.

Return on Equity (ROE)	-26.27%
Return on Assets (ROA)	-16.63%
Return on Invested Capital (ROIC)	-16.87%
Return on Capital Employed (ROCE)	-31.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6492 has paid 1.28 million in taxes.

Income Tax	1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.52% in the last 52 weeks. The beta is 0.77, so TPEX:6492's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-27.52%
50-Day Moving Average	33.72
200-Day Moving Average	41.62
Relative Strength Index (RSI)	41.99
Average Volume (20 Days)	336,598

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -291.97 million in losses. Loss per share was -3.27.

Revenue	1.00M
Gross Profit	470,000
Operating Income	-304.39M
Pretax Income	-290.69M
Net Income	-291.97M
EBITDA	-302.16M
EBIT	-304.39M
Loss Per Share	-3.27

Full Income Statement

Balance Sheet

The company has 959.50 million in cash and 11.94 million in debt, giving a net cash position of 947.56 million or 10.62 per share.

Cash & Cash Equivalents	959.50M
Total Debt	11.94M
Net Cash	947.56M
Net Cash Per Share	10.62
Equity (Book Value)	966.44M
Book Value Per Share	10.84
Working Capital	945.39M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-279.82M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	47.00%
Operating Margin	-30,439.40%
Pretax Margin	-29,068.70%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6492 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.10%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6492 has an Altman Z-Score of 84.61 and a Piotroski F-Score of 1.

Altman Z-Score	84.61
Piotroski F-Score	1